European attitudes to gene therapy and pharmacogenetics

Drug Discovery Today

Volumn 16, Issue 19-20, 2011, Pages 843-847

  Hudson, John ^a   Orviska, Marta ^b  

^a University of Bath   (United Kingdom)

^b MATEJ BEL UNIVERSITY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ATTITUDE TO HEALTH; CHILDHOOD LEUKEMIA; CLINICAL PRACTICE; DRUG SAFETY; GENE THERAPY; GENETIC ANALYSIS; GOVERNMENT REGULATION; HEALTH CARE POLICY; HUMAN; IN VITRO STUDY; NANOTECHNOLOGY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; ONCOGENE; PHARMACOGENETICS; REVIEW;

EID: 80053935845     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2011.06.008     Document Type: Editorial

References (20)

1. M.M. Hopkins Putting pharmacogenetics into practice Nature Biotechnology 24 2006 403 410
2. M. Cavazzana-Calvo The future of gene therapy Nature 427 2004 779 781 (Pubitemid 38297723)
3. S.J.H. Vijvberg Ethical and social issues in pharmacogenomics testing Current Pharmaceutical Design 16 2010 245 252
4. D. Ibarreta Towards quality assurance and harmonization of genetic testing services in the European Union Nature Biotechnology 22 2004 1230 1235 (Pubitemid 39336771)
5. A. Corvelyn Provision and quality assurance of preimplementation genetic diagnosis in Europe European Journal of Human Genetics 16 2008 290 299
6. P. Gonin Gene therapy bio-safety: scientific and regulatory issues Gene Therapy 12 2005 146 152
7. S.M. Wolf Gene therapy oversight: lessons for nanobiotechnology Journal of Law, Medicine and Ethics 37 2009 659 684
8. J. Kuzma Evaluating oversight systems for emerging technologies: a case study of genetically engineered organisms Journal of Law, Medicine & Ethics 37 2009 546 586
9. S. Gaisser EU policies in personalized medicine-related technologies Personalized Medicine 6 2007 93 102
10. ® infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnostics Journal of Clinical Virology 30 2004 S6 S10
11. R.A. Salerno, and L.J. Lesko Pharmacogenomics in drug development and regulatory decision making: The Genomic Data Submission (GDS) Proposal Pharmacogenomics 5 2004 25 30 (Pubitemid 38088478)
12. S. Bates Progress towards personalized medicine Drug Discovery Today 15 2010 115 120
13. L.J. Lesko Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWGPhRMA-DruSafe Workshop Journal of Clinical Pharmacology 43 2003 342 358 (Pubitemid 36368777)
14. European Commission (2009) Assessment of the functioning of the "Clinical Trials Directive" 2001/20/EC: Public consultation paper, http://ec.europa.eu/health/files/clinicaltrials/docs/2009-10-09-public- consultation-paper.pdf
15. J. Hear, and R. Sullivan The impact of the 'Clinical Trials' directive on the cost and conduct of non-commercial cancer trials in the UK European Journal of Cancer 43 2007 8 13 (Pubitemid 46054481)
16. D. Gurwitz Pharmacogenetics in Europe: barriers and opportunities Public Health Genomics 12 2009 134 141
17. N.A. Jianakoplos, and A. Bernasek Are women more risk averse? Economic Inquiry 36 1998 620 630 (Pubitemid 128351549)
18. D. Shalala Protecting research subjects - what must be done The New England Journal of Medicine 343 2000 808 810
19. J. Chopyak, and P. Levesque Public participation in science and technology decision making: trends for the future Technology in Society 24 2002 155 166 (Pubitemid 34281475)
20. S.J.L. Edwards Research ethics committees and paternalism Journal of Medical Ethics 30 2004 88 91 (Pubitemid 38262816)